AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Shire announces vaccines alliance.(Shire Pharmaceuticals Group PLC)(Brief Article)
2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Shire Pharmaceuticals Group, plc, announced that it has entered into a commercial agreement with Berna Biotech, AG, of Switzerland.
Under the agreement, Shire will manufacture and supply its Fluviral influenza vaccine to Berna Biotech for sale in international territories excluding Europe and North America. In return, Berna Biotech will manufacture and supply its hepatitis B vaccines, Hepavax Gene and Bio-Hep B and make them available to Shire for exclusive sale in Europe.
Shire Biologics, part of the Shire Group, began its vaccine operations more than a decade ago when it purchased the vaccine operations of the Armand-Frappier Institute, which had been producing and selling vaccines for many years. Shire Biologics' current commercial products are Fluviral and Pacis for superficial bladder cancer.
Commenting on the agreement, Richard de Souza, director international, ...
- BERNA BIOTECH PAYING EUR279M IN CASH, SHARES FOR RHEIN BIOTECH.(Brief...
- Magazine article from: BIOWORLD Today Sheridan, Cormac May 24, 2002 700+ words
Switzerland's Berna Biotech Ltd. is acquiring Rhein Biotech...shareholders will be offered 1.42 Berna Biotech shares plus EUR33.75 in cash...proposed 1:25 share split of Berna Biotech's stock is approved at its annual...
- Berna Biotech Paying EUR279M In Cash, Shares For Rhein Biotech.
- Magazine article from: BIOWORLD Today November 4, 2009 700+ words
...International Correspondent Switzerland's Berna Biotech Ltd. is acquiring Rhein Biotech NV...shareholders will be offered 1.42 Berna Biotech shares plus EUR33.75 in cash. Based...assuming a proposed 1:25 share split of Berna Biotech's stock is approved at its annual...
- Crucell Acquiring Berna Biotech In US$449M All-Share Takeover.
- Magazine article from: BIOWORLD Today Sheridan, Cormac December 2, 2005 700+ words
...agreed to an all-share takeover of Berna Biotech AG in a deal valued at CHF591 million...million). The transaction values Berna Biotech's stock at CHF15.72 (US$11...its three-month trading average. Berna Biotech shareholders will be offered 0.447...
- Berna Biotech slapped with 11-item 483 for media fills: Berna Biotech, Berne,...
- Newspaper article from: Inspection Monitor May 1, 2008 700+ words
Berna Biotech, Berne, Switzerland, received an...the audit. The report stated that Berna Biotech is a vaccine manufacturer. Only the...performed or information communicated to Berna Biotech. "The only information related to...
- Berna Biotech cited for faulty media fill procedures.(Human drugs)
- Newspaper article from: Validation Times Pickett, Joseph May 1, 2008 700+ words
Berna Biotech, Berne, Switzerland, was hit with...the audit. The report stated that Berna Biotech is a vaccine manufacturer. Only the...specifications in the agreement between Berna Biotech and an undisclosed firm related to...
- Dynavax Technologies and Berna Biotech Announce Collaboration.
- Press release article from: PR Newswire November 3, 2003 700+ words
...Dynavax Technologies Corporation and Berna Biotech Ltd. today announced execution of...details were disclosed. About Berna Berna Biotech Ltd. (Swiss Exchange: BBIN) develops...subsidiaries in Europe and Korea, Berna Biotech employs approximately 900 people...
- Corixa Announces First Approval of an Infectious Disease Vaccine Containing the...
- Press release article from: Business Wire September 8, 2003 700+ words
...the Argentinean approval of SUPERVAX, Berna Biotech's prophylactic vaccine containing Corixa...of Hepatitis B infection. Developed by Berna Biotech, the vaccine combines Berna Biotech's Hansenula polymorpha-based recombinant...
- Berna Biotech vaccine sales rise 44%.
- Newspaper article from: Pharma Marketletter February 3, 2003 700+ words
Although Switzerland's Berna Biotech reported a 33% slump in gross revenues for 2002 at 202.8 billion Swiss francs ($149.9 million), which includes the business...
Source: HighBeam Research, Shire announces vaccines alliance.(Shire Pharmaceuticals Group...